Apple Rallies Most Since May on Strong iPhone Pre-Order Data

(Bloomberg) — Apple Inc. shares rallied the most since May as pre-order data showed the iPhone 14 Pro Max was the best selling model, surpassing what the older version did in a similar timeframe.

Shares of the tech giant rose 3.9%, their biggest one-day gain since May 27, and the stock closed above its 200-day moving average for the first time since August. Analysts from JPMorgan to Barclays wrote that the data point to strong demand for the latest mobile phone series, which was unveiled at its product launch event last week.

“Pre-order data shows that the iPhone 14 Pro Max is the best-selling model, and that it is doing better than the iPhone 13 Pro Max did at this point,” KGI Securities analyst Christine Wang wrote in a report. The pricing of the iPhone 14 series is positive for its future sales, she added.

At its biggest product launch of the year, Apple introduced the iPhone 14, fresh AirPods Pro earbuds and new Apple Watch models. The iPhone retains the general look of the older version while getting camera enhancements and a long-anticipated satellite-messaging feature. The bulk of the iPhone upgrades are coming to the higher-end Pro line. Those devices will get a 48-megapixel camera and a screen that’s capable of always staying on in a low-power mode, similar to recent versions of the Apple Watch.

Apple is the top performing megacap technology stock this year, because investors have faith in its ability to tap into its more than 1 billion customers to earn more on its services including apps, video, fitness and gaming subscriptions. The next catalyst for the stock will be earnings for the September quarter, which is expected in late October.

Its shares are about 8% lower this year compared with the Nasdaq 100 Index, which has slumped about 22%. About 96% of the 50 analysts covering the stock recommend either buying Apple shares or holding on to their positions, while only two suggest selling, according to data compiled by Bloomberg.

 

More stories like this are available on bloomberg.com.

©2022 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Image

Latest

Chase Harris
Faith, Fatherhood, and Fortitude: Inside Chase Harris’ Mission to Make Accessibility Possible for Every Child
October 15, 2025

Chase Harris is a father, husband, entrepreneur, and all-around force of light. Alongside his wife, Carly, and their son, Cash, he has inspired millions online through messages of resilience, faith, and family. Their story is one of turning adversity into action — and hardship into hope. “We knew early on that Cash had this special…

Read More
accounting career
How Shanice Scott Reinvented Her Accounting Career — And Found Her ‘Why’
October 15, 2025

The accounting pipeline is in flux. After years of decline in new graduates, the AICPA reported that bachelor’s completions fell 7.8% in 2021–22 and master’s fell 6.4%. In Fall 2024, undergraduate accounting enrollment rebounded by about 12%, while graduate enrollment continued to dip, underscoring a profession still recalibrating its talent model. For those building or…

Read More
Faherty
From Heritage to Hospitality: The Faherty Blueprint for Authentic, Community-Centered Branding
October 15, 2025

Great clothes may be where it starts, but today’s shoppers are looking for something more — a sense of connection, belonging, and shared purpose. Research shows that 90% of consumers value authenticity when deciding which brands to support: a clear reminder that while quality and design remain vital, meaning has become the new measure of loyalty….

Read More
Food-as-Medicine
The Gut Reset Revolution: How Food-as-Medicine Became the New Foundation for Wellness
October 15, 2025

Gut health has moved from fringe to front page, with consumers overwhelmed by protocols, powders, and “miracle” cleanses. As interest surges, so do questions about what actually works day to day—and why it matters now. One reason: an estimated 65% of the population is dairy intolerant, complicating popular bovine colostrum trends cited for immunity…

Read More